ACTIVE

APOTHEEK DIRK VAN HERCK

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

54,2 k €

+200.8% YoY

Gross margin

243,5 k €

-26.5% YoY

Equity

-113,1 k €

+32.4% YoY

Workforce

2,4 ETP

-22.6% YoY

What does APOTHEEK DIRK VAN HERCK do?

APOTHEEK DIRK VAN HERCK is a Private limited company incorporated in 1994. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Nijlen. It employs on average 2,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0453.580.413

Incorporation

18/10/1994

Legal form

Private limited company

Registered office

Albert Kanaalstraat 50
2560 Nijlen · FlandreSee on map

Contributed capital

18 592,01 €

Latest accounts

31/12/2025

Average workforce

2,4 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	243,5 k €	-26.5%	331,3 k €	+16.7%	283,9 k €	+91.7%	148,1 k €	-22.6%	191,3 k €	+5.0%	182,3 k €	-8.5%	199,2 k €	+3.0%	193,4 k €	-17.4%	234,1 k €	+0.4%	233 k €	+5.7%	220,5 k €	-4.1%	229,8 k €	+10.8%	207,4 k €	+32.2%	156,9 k €	+20.3%	130,4 k €	+7.9%	120,9 k €	+16.2%	104,1 k €	-24.5%	137,8 k €	-1.3%	139,6 k €	+111%	66,3 k €
EBITDA	133,8 k €	+24.8%	107,2 k €	+26.9%	84,5 k €	+262%	-52,3 k €	-42.4%	-36,7 k €	-652%	-4,9 k €	-115%	33,6 k €	+567%	5 k €	-82.5%	28,8 k €	-8.6%	31,5 k €	+60.8%	19,6 k €	-45.4%	36 k €	-73.7%	136,7 k €	+47.7%	92,6 k €	+22.1%	75,8 k €	-6.4%	81 k €	+18.3%	68,5 k €	-34.1%	104 k €	-2.1%	106,2 k €	+153%	42 k €
Operating result	87,2 k €	+37.4%	63,5 k €	+56.6%	40,5 k €	+132%	-126,5 k €	-94.4%	-65,1 k €	-73.3%	-37,6 k €	-287%	20,1 k €	+291%	-10,5 k €	-175%	14,1 k €	+73.8%	8,1 k €	+265%	-4,9 k €	-123%	21,1 k €	-81.4%	113,4 k €	+68.2%	67,4 k €	+33.4%	50,5 k €	-6.0%	53,8 k €	+34.5%	40 k €	-47.0%	75,4 k €	-3.2%	77,8 k €	+316%	18,7 k €
Net result	54,2 k €	+201%	18 k €	+946%	-2,1 k €	+98.5%	-144,5 k €	-139%	-60,5 k €	-1790%	-3,2 k €	-106%	53,1 k €	+207%	17,3 k €	-43.1%	30,4 k €	-27.5%	41,8 k €	+50.7%	27,8 k €	-53.0%	59 k €	-30.7%	85,2 k €	+72.6%	49,4 k €	+23.4%	40 k €	-0.2%	40,1 k €	+19.0%	33,7 k €	-41.2%	57,3 k €	+3.8%	55,2 k €	+270%	14,9 k €
Balance sheet
Equity	-113,1 k €	+32.4%	-167,2 k €	+9.7%	-185,2 k €	-1.2%	-183,1 k €	-374%	-38,6 k €	-277%	21,9 k €	-12.8%	25,1 k €	+0.4%	25 k €	-96.2%	653,5 k €	+3.0%	634,6 k €	+0.7%	630,3 k €	+1.1%	623,5 k €	+2.2%	610 k €	+16.2%	524,7 k €	+10.4%	475,4 k €	+9.2%	435,3 k €	+2.4%	425,2 k €	+8.6%	391,4 k €	+17.2%	334,1 k €	+19.8%	278,9 k €
Total assets	1,8 M €	-1.0%	1,8 M €	-7.4%	1,9 M €	+0.2%	1,9 M €	+89.7%	1 M €	-15.0%	1,2 M €	+60.1%	748,6 k €	+37.5%	544,6 k €	-49.8%	1,1 M €	-0.1%	1,1 M €	+12.0%	969 k €	-14.9%	1,1 M €	+57.3%	724,2 k €	+13.7%	637,1 k €	+15.5%	551,7 k €	-4.5%	577,6 k €	+1.1%	571,1 k €	+3.7%	550,6 k €	+0.7%	546,7 k €	+17.0%	467,4 k €
Cash	76,9 k €	+96.1%	39,2 k €	-7.3%	42,3 k €	-39.0%	69,3 k €	-20.1%	86,7 k €	-53.0%	184,3 k €	-20.8%	232,6 k €	+96.1%	118,6 k €	-36.6%	187,2 k €	-25.6%	251,6 k €	+145%	102,9 k €	+34.0%	76,8 k €	-80.1%	385,5 k €	+53.0%	251,9 k €	+15.5%	218,1 k €	+12.7%	193,5 k €	+20.7%	160,3 k €	+34.3%	119,4 k €	+37.8%	86,6 k €	-29.7%	123,3 k €
Debts	1,9 M €	-3.4%	1,9 M €	-7.7%	2,1 M €	-0.1%	2,1 M €	+99.9%	1,1 M €	-10.1%	1,2 M €	+62.6%	722,9 k €	+39.3%	518,9 k €	+20.8%	429,7 k €	-4.5%	450 k €	+33.8%	336,3 k €	-34.4%	513 k €	+349%	114,2 k €	+1.6%	112,4 k €	+55.2%	72,4 k €	-47.7%	138,3 k €	-1.2%	140 k €	-12.0%	159,1 k €	-25.1%	212,6 k €	+12.8%	188,5 k €
Other
Workforce	2,4 ETP	-22.6%	3,1 ETP	0.0%	3,1 ETP	+3.3%	3,0 ETP	0.0%	3,0 ETP	+11.1%	2,7 ETP	-12.9%	3,1 ETP	+3.3%	3,0 ETP	0.0%	3,0 ETP	0.0%	3,0 ETP	+3.4%	2,9 ETP	+20.8%	2,4 ETP	+71.4%	1,4 ETP	0.0%	1,4 ETP	+55.6%	0,9 ETP	+80.0%	0,5 ETP	-16.7%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	+50.0%	0,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Mees Joris

Active

Ended mandates

MEES MANAGEMENT IMMO

Manager · since 31 mars 2014 · 0471.290.633

Represented by Joris Mees

Ended

ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Joris Mees

Ended

ANTWERP PHARMACIES

Director · 0700.733.344

Ended

ANTWERP PHARMACIES

Manager · 0700.733.344

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	24/06/2025	01/07/2024	05/07/2023	19/07/2022	18/06/2021
General meeting	16/06/2026	17/06/2025	18/06/2024	20/06/2023	21/06/2022	15/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	16/06/2026	02/07/2026	Dutch	PDF
Abridged model	31/12/2024	17/06/2025	24/06/2025	Dutch	PDF
Abridged model	31/12/2023	18/06/2024	01/07/2024	Dutch	PDF
Abridged model	31/12/2022	20/06/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	21/06/2022	19/07/2022	Dutch	PDF
Abridged model	31/12/2020	15/06/2021	18/06/2021	Dutch	PDF
Abridged model	31/12/2019	16/06/2020	26/06/2020	Dutch	PDF
Abridged model	31/12/2018	18/06/2019	04/07/2019	Dutch	PDF
Abridged model	31/12/2017	19/06/2018	29/06/2018	Dutch	PDF
Abridged model	31/12/2016	20/06/2017	14/07/2017	Dutch	PDF
Abridged model	31/12/2015	21/06/2016	21/06/2016	Dutch	PDF
Abridged model	31/12/2014	16/06/2015	09/07/2015	Dutch	PDF
Abridged model	31/12/2013	17/06/2014	07/07/2014	Dutch	PDF
Abridged model	31/12/2012	18/06/2013	24/06/2013	Dutch	PDF
Abridged model	31/12/2011	19/06/2012	09/07/2012	Dutch	PDF
Abridged model	31/12/2010	21/06/2011	08/07/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	29/07/2010	Dutch	PDF
Abridged model	31/12/2008	16/06/2009	01/07/2009	Dutch	PDF
Abridged model	31/12/2007	19/06/2008	24/07/2008	Dutch	PDF
Abridged model	31/12/2006	21/06/2007	16/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Mees Joris

Active

Ended mandates

MEES MANAGEMENT IMMO

Manager · since 31 mars 2014 · 0471.290.633

Represented by Joris Mees

Ended

ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Joris Mees

Ended

ANTWERP PHARMACIES

Director · 0700.733.344

Ended

ANTWERP PHARMACIES

Manager · 0700.733.344

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other07/10/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING
PDF
Mandates18/11/2020
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates07/01/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/09/2015
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/05/2014
ONTSLAGEN - BENOEMINGEN
PDF
Other05/01/2005
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202554,2 k €↑
2024
Annual accounts 202418 k €↑
2023
Annual accounts 2023-2,1 k €↑
2022
Annual accounts 2022-144,5 k €↓
2022
Name changeDirk Van Herck Apotheek
2021
Annual accounts 2021-60,5 k €↓
2021
Name changeAPOTHEEK DIRK VAN HERCK
2020
Annual accounts 2020-3,2 k €↓
2019
Annual accounts 201953,1 k €↑
2018
Annual accounts 201817,3 k €↓
2017
Annual accounts 201730,4 k €↓
2016
Annual accounts 201641,8 k €↑
2015
Annual accounts 201527,8 k €↓
2014
Annual accounts 201459 k €↓
2013
Annual accounts 201385,2 k €↑
2012
Annual accounts 201249,4 k €↑
2011
Annual accounts 201140 k €↓
2010
Annual accounts 201040,1 k €↑
2009
Annual accounts 200933,7 k €↓
2008
Annual accounts 200857,3 k €↑
2007
Annual accounts 200755,2 k €↑
2006
Annual accounts 200614,9 k €
2006
Name changeAPOTEEK DIRK VAN HERCK
18/10/1994
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK DIRK VAN HERCK

Overview

What does APOTHEEK DIRK VAN HERCK do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline